<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Publications – Xubin Li, PhD</title>
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <!-- Font -->
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600&display=swap" rel="stylesheet">

  <style>
    body {
      margin: 0;
      font-family: "Inter", system-ui, -apple-system, BlinkMacSystemFont, sans-serif;
      background: #ffffff;
      color: #222;
      line-height: 1.6;
    }
    .page {
      max-width: 1000px;
      margin: 0 auto;
      padding: 24px 16px 48px;
    }
    header {
      display: flex;
      justify-content: space-between;
      align-items: center;
      padding-bottom: 12px;
      border-bottom: 1px solid #e0e0e0;
      margin-bottom: 32px;
    }
    nav a {
      margin-left: 16px;
      text-decoration: none;
      color: #555;
      font-weight: 500;
    }
    nav a:hover { color: #0f6abf; }
    nav a.active {
      color: #0f6abf;
      border-bottom: 2px solid #0f6abf;
      padding-bottom: 3px;
    }
    h1 { margin-top: 0; }
    h2 {
      margin-top: 40px;
      margin-bottom: 10px;
      font-size: 1.25rem;
      color: #0f6abf;
    }
    ol {
      padding-left: 20px;
    }
  </style>
</head>

<body>
  <div class="page">

    <!-- HEADER -->
    <header>
      <!-- <div class="site-title">Xubin Li Lab</div> -->
      <nav>
        <a href="index.html">Home</a>
        <a href="research.html">Research</a>
        <a href="publications.html" class="active">Publications</a>
        <a href="code.html">Code</a>
      </nav>
    </header>

    <main>

      <h1>Publications</h1>

      <!-- Section 1 -->
      <h2>Tumor Microenvironment & Lymphoma Biology</h2>
      <ol>
        <li>
          <b>Li X</b>, Singhal K, Deng Q, Chihara D, Russler-Germain D, Harkins RA, Henderson J, 
          Arita K, Kizhakeyil A, Sun R, Lakra P, Hussein U, Foltz JA, Wilson A, Schmidt E, 
          Nizamuddin I, Dinh T, Kesaraju A, Hamilton MP, Allen C, Gandhi MK, Tobin J, Jiang A, 
          Hilton L, Scott DW, Vega F, Flowers CR, Westin JR, Griffith OL, Fehniger TA, Griffith M, 
          Green MR. Large B cell lymphoma microenvironment archetype profiles. 
          <i>Cancer Cell</i>. 2025 Jul 14; 43(7):1347-1364.e13.
        </li>

        <li>
          Dai Y, Kizhakeyil A, Chihara D, <b>Li X</b>, Liu Y, Sainz Zuniga TP, Wilson A, Henderson J, 
          Vibe D, Petrosyants A, Jacobson C, Sarachakov A, Nomie K, Kryukov K, Bagaev A, Chauhan A, 
          Westin JR, Flowers CR, Vega F, Wang L, Green MR. Multi-modal spatial characterization of 
          tumor immune microenvironments identifies targetable inflammatory niches in diffuse large 
          B cell lymphoma. <i>Nature Genetics</i>. 2025.
        </li>

        <li>
          Deng Q, Lakra P, Gou P, Yang H, Meydan C, Teater M, Chin C, Zhang W, Dinh T, Hussein U, 
          <b>Li X</b>, Rojas E, Liu W, Reville PK, Kizhakeyil A, Barisic D, Parsons S, Wilson A, 
          Henderson J, Scull B, Gurumurthy C, Vega F, Chadburn A, Cuglievan B, El-Mallawany NK, 
          Allen C, Mason C, Melnick A, Green MR. SMARCA4 is a haploinsufficient B cell lymphoma 
          tumor suppressor that fine-tunes centrocyte cell fate decisions. 
          <i>Cancer Cell</i>. 2024 Apr 08; 42(4):605-622.e11.
        </li>

        <li>
          Han G, Deng Q, Marques-Piubelli ML, Dai E, Dang M, Ma MCJ, <b>Li X</b>, Yang H, Henderson J, 
          Kudryashova O, Meerson M, Isaev S, Kotlov N, Nomie KJ, Bagaev A, Parra ER, Solis Soto LM, 
          Parmar S, Hagemeister FB, Ahmed S, Iyer SP, Samaniego F, Steiner R, Fayad L, Lee H, Fowler NH, 
          Flowers CR, Strati P, Westin JR, Neelapu SS, Nastoupil LJ, Vega F, Wang L, Green MR. 
          Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and 
          MHC Class II Expression. <i>Blood Cancer Discovery</i>. 2022 Sep 06; 3(5):428-443.
        </li>
      </ol>

      <!-- Section 2 -->
      <h2>CAR T Cell Therapy</h2>
      <ol start="5">
        <li>
          <b>Li X</b>, Henderson J, Gordon MJ, Sheikh IN, Nastoupil L, Westin JR, Flowers CR, Ahmed S, 
          Wang L, Neelapu SS, Strati P, Deng Q, Green M. A single-cell atlas of CD19 chimeric antigen 
          receptor T cells. <i>Cancer Cell</i>. 2023 Nov 13; 41(11):1835-1837.
        </li>

        <li>
          Strati P<sup>1</sup>, <b>Li X<sup>1</sup></b>, Deng Q<sup>1</sup>, Marques-Piubelli ML, Henderson J, 
          Watson G, Deaton FL, Cain JT, Yang H, Ravanmehr V, Fayad LE, Iyer SP, Nastoupil L, 
          Hagemeister FB, Parra ER, Saini N, Takahashi K, Fowler N, Westin JR, Steiner RE, 
          Nair R, Flowers CR, Wang L, Ahmed S, Al-Atrash G, Vega F, Neelapu SS, Green M. 
          Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration 
          of clonally expanded IFNγ-expressing CD8 T cells. 
          <i>Cell Reports Medicine</i>. 2023 Aug 15; 4(8):101158.
          (1 = Co-first authors)
        </li>

        <li>
          Strati P, Jallouk AP, Deng Q, <b>Li X</b>, Feng L, Sun R, Adkins S, Johncy S, Cain T, Steiner RE, 
          Ahmed S, Chihara D, Fayad LE, Iyer S, Horowitz S, Nastoupil L, Nair R, Hassan A, Daoud T, 
          Hawkins MC, Rodriguez MA, Shpall E, Ramdial JL, Kebriaei P, Hong DS, Westin JR, Neelapu SS, 
          Green M. A phase 1 study of prophylactic anakinra to mitigate ICANS. 
          <i>Blood Advances</i>. 2023 Jan 01; 7(21):6785-6789.
        </li>

        <li>
          Reville PK, Sheikh IN, Choi A, Dai E, Henderson J, <b>Li X</b>, Rojas E, Le C, Okwuchi C, Devonish M, 
          Carrio R, Pate N, Malley K, Bangari D, Givigan JA, Shi C, Liu B, Byers T, Westin J, Ahmed S, 
          Fowler N, Fayad L, Lee HJ, Nastoupil L, Sassoon I, Cucchetti M, Wang R, Agarwal M, Abbadessa G, 
          Meng R, Meibalan E, Powers L, Cao J, Ying X, Balko K, Yu Q, Jiao J, Cortez-Retamozo V, Sidhu S, 
          Shaffer D, Neelapu S, Wang L, <b>Li X</b>, Green M. 
          CD8 T-cell dysfunction is linked with CAR T-cell failure and can be mitigated by a non-alpha 
          IL-2 agonist. <i>bioRxiv</i>. 2023 Aug 28.
        </li>
      </ol>

      <!-- Section 3 -->
      <h2>Bioinformatics & Pan-Cancer Genomics</h2>
      <ol start="9">
        <li><b>Li X</b>, Dowling EK, Yan G, Dereli Korkut Z, Bozorgui B, Imanirad P, Elnaggar JH, Luna A, Menter DG, Pilie PG, Yap TA, Kopetz S, Sander C, Korkut A. Precision Combination Therapies Based on Recurrent Oncogenic Coalterations. <i>Cancer Discovery</i>. 2022 Jun 01; 12(6):1542-1559.</li>
        <li><b>Li X</b>, Nguyen J, Korkut A. Recurrent composite markers of cell types and states. <i>bioRxiv</i>. 2023 Jul 19.</li>
        <li>Vishnoi M, Dereli Z, Yin Z, Kong EK, Kinali M, Thapa K, Babur O, Yun K, Abdelfattah N, <b>Li X</b>, Bozorgui B, Rostomily RC, Korkut A. A prognostic matrix code defines functional glioblastoma phenotypes and niches. <i>bioRxiv</i>. 2023 Jun 8.</li>
        <li>Yan G, Luna A, Wang H, Bozorgui B, <b>Li X</b>, Sanchez M, Dereli Korkut Z, Kahraman N, Kara G, Chen X, Zheng C, McGrail DJ, Sahni N, Lu Y, Babur Ö, Cokol M, Lim B, Ozpolat B, Sander C, Mills GB, Korkut A. BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancer. <i>Cell Reports</i>. 2022 Sep 13; 40(11).</li>
        <li>Wang H, Luna A, Yan G, <b>Li X</b>, Babur O, Mills GB, Sander C, Korkut A. Targeting Adaptation to Cancer Treatment by Drug Combinations. <i>bioRxiv</i>. 2021.</li>
        <li>Donehower LA, Soussi T, Korkut A, Liu Y, Schultz A, Cardenas M, <b>Li X</b>, Babur O, Hsu TK, Lichtarge O, Weinstein JN, Akbani R, Wheeler DA. Integrated Analysis of TP53 Gene Alterations. <i>Cell Reports</i>. 2019.</li>
        <li>Korkut A, Zaidi S, Kanchi RS, Rao S, Gough NR, Schultz A, <b>Li X</b>, Lorenzi PL, Berger AC, et al. High-Frequency Genetic Alterations in TGF-β Pathway. <i>Cell Systems</i>. 2018.</li>
        <li>Berger AC, Korkut A, Kanchi RS, Hegde AM, Liu W, Liu Y, Fan H, Shen H, Ravikumar V, Rao A, Schultz A, <b>Li X</b>, et al. Pan-Cancer Study of Gynecologic and Breast Cancers. <i>Cancer Cell</i>. 2018.</li>
      </ol>

      <!-- Section 4 -->
      <h2>Biophysics</h2>
      <ol start="17">
        <li><b>Li X</b>, Qu T, Zheng L, Yang W. Gaussian Kernel Monte Carlo Resampling. <i>J Chem Phys</i>. 2025.</li>
        <li>Lu C<sup>1</sup>, <b>Li X<sup>1</sup></b>, Wu D, Zheng L, Yang W. Predictive Sampling Method. <i>JCTC</i>. 2016. (1 = Co-first authors)</li>
        <li><b>Li X</b>, Lv C, Corbett KM, Zheng L, Wu D, Yang W. Free energy landscape of a salt bridge model. <i>Protein Science</i>. 2016.</li>
      </ol>

      <!-- Section 5 -->
      <h2>Conference Abstracts</h2>
      <ol start="20">
        <li>Russler-Germain DA, <b>Li X</b>, Singhal K, Deng Q, Chihara D, Hussein U, Foltz JA, Henderson J, Wilson A, et al. LymphoMAPs for CAR T-cell therapy. <i>Hematological Oncology</i>. 2025.</li>
        <li><b>Li X</b>, Singhal K, Deng Q, Chihara D, Russler-Germain DA, Hussein U, Foltz JA, Henderson J, Wilson A, et al. Tumor Microenvironment in R/R LBCL. <i>Blood</i>. 2024.</li>
        <li><b>Li X</b>, Deng Q, Henderson J, Watson G, Deaton L, Cain T, Fayad L, et al. Etiology of Prolonged Cytopenia after CAR T. <i>Blood Cancer Discovery</i>. 2024.</li>
        <li>Strati P, <b>Li X</b>, Deng Q, Feng L, Sun R, Jallouk A, Adkins S, et al. Prophylactic Anakinra in LBCL. <i>Blood</i>. 2022.</li>
      </ol>

    </main>

  </div>
</body>
</html>
